Loading company
PTC Therapeutics, Inc.
PTCT · Nasdaq · ·
Next earnings: November 3, 2026
$64.96-1.5%Sep 29 close
- 1M
- -7.3%
- 6M
- -1.0%
- 1Y
- +5.8%
- 5Y
- +66.9%
PTCT · Nasdaq · ·
Next earnings: November 3, 2026
$64.96-1.5%Sep 29 close
PTC Therapeutics, Inc. is scheduled to report next on November 3, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $360.5M | $178.9M | +101.55% |
| Profit | $83.5M | -$64.8M | +228.75% |
| Profit per share | $0.92 | -$0.83 | +210.84% |
| Free Cash Flow | $126.9M | -$59.6M | +313.03% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Releases land after the close or before the open, so the move is the session that follows.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company’s strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow on LinkedIn, X, Facebook and Instagram.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from PTC Therapeutics, Inc.’s Item 2.02 8-K filed July 30, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
PTC Therapeutics, Inc. has no earnings call transcript available.